Clinical Trial

A Study to Evaluate the Efficacy of Guselkumab in Chinese Participants With Crohn's Disease (CD)

Name: A Study to Evaluate the Efficacy of Guselkumab in Chinese Participants With Crohn's Disease (CD) — clinical trial record (NCT07310095)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

The purpose of this study is to evaluate how well guselkumab works in participants with Crohn's disease (CD; a long-term condition causing severe inflammation of the intestinal tract) who no longer respond to treatment with ustekinumab.

Trial Details

NCT Number	NCT07310095
Lead Sponsor	Xian-Janssen Pharmaceutical Ltd.
Conditions	Crohn Disease
Enrollment	78 participants
Start Date	2025-12-30
Primary Completion	2027-09-15 (estimated)
Study Completion	2027-11-15 (estimated)
Updated on ClinicalTrials.gov	2026-07-06